Sichuan, China

Zheng Gong

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sichuan Kelan Pharmaceutical Research Institute Co., Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zheng Gong. Retrieved from https://idiyas.com/inventor/zheng-gong-jsvvdcn2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zheng Gong: Innovator in Pharmaceutical Research

Introduction

Zheng Gong is a notable inventor based in Sichuan, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds for medical applications. His work focuses on improving treatments for various health conditions, showcasing his dedication to innovation in medicine.

Latest Patents

Zheng Gong holds a patent for a crystal form of 4-phenylthiazole derivative and its preparation method. This invention relates to a pharmaceutical composition that includes this crystal form, which is utilized in the manufacture of a medicament for treating thrombocytopenia. His innovative approach aims to enhance the efficacy and stability of pharmaceutical products.

Career Highlights

Zheng Gong is affiliated with the Sichuan Kelan Pharmaceutical Research Institute Co., Ltd. His role at the institute allows him to engage in cutting-edge research and development, contributing to advancements in the pharmaceutical industry. His expertise and innovative mindset have positioned him as a valuable asset in his field.

Collaborations

Zheng Gong collaborates with esteemed colleagues such as Shidong Yi and Chengxi Yang. These partnerships foster a collaborative environment that encourages the exchange of ideas and enhances the research outcomes at the institute.

Conclusion

Zheng Gong's contributions to pharmaceutical research exemplify the impact of innovation in medicine. His patent for the crystal form of 4-phenylthiazole derivative highlights his commitment to developing effective treatments for thrombocytopenia. Through his work, he continues to advance the field and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…